Foghorn Therapeutics (FHTX) Net Equity Issued and Repurchased (2020 - 2026)
Foghorn Therapeutics' Net Equity Issued and Repurchased was $50 million in Q1 2026, compared with $139,000 a year earlier.
Powered by 
Analysis
Foghorn Therapeutics (FHTX) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends
For FY2025, Net Equity Issued and Repurchased at Foghorn Therapeutics came in at $483,000, down 81.5% from FY2024.
- Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -66.9% (FY2020 to FY2025).
- In earlier years, Net Equity Issued and Repurchased was $2.61 million in FY2024 (+46.9%), $1.78 million in FY2023 (+0.9%), $1.76 million in FY2022 (-95.8%) and $42.21 million in FY2021 (-65.4%).
- The Q1 2026 figure marks the highest quarterly Net Equity Issued and Repurchased since Q2 2024.
- The best year-over-year quarter for Net Equity Issued and Repurchased over five years was Q2 2022 (growth of 827.9%); the worst was Q4 2022 (a decline of 100.0%).
- Per Business Quant data, FHTX's Net Equity Issued and Repurchased in the three quarters before Q1 2026 was $41,000 (Q4 2025), $49,000 (Q3 2025) and $254,000 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Foghorn Therapeutics | 209.61 Mn | -116.34 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 50.00 Mn |
| Dec 31, 2025 | 41,000.00 |
| Sep 30, 2025 | 49,000.00 |
| Jun 30, 2025 | 254,000.00 |
| Mar 31, 2025 | 139,000.00 |
| Dec 31, 2024 | -100.79 Mn |
| Jun 30, 2024 | 102.23 Mn |
| Mar 31, 2024 | 1.17 Mn |
| Dec 31, 2023 | 186,000.00 |
| Sep 30, 2023 | 1.39 Mn |
| Jun 30, 2023 | 103,000.00 |
| Mar 31, 2023 | 102,000.00 |
| Dec 31, 2022 | 16,000.00 |
| Sep 30, 2022 | 333,000.00 |
| Jun 30, 2022 | 1.03 Mn |
| Mar 31, 2022 | 384,000.00 |
| Dec 31, 2021 | 41.53 Mn |
| Sep 30, 2021 | 505,000.00 |
| Jun 30, 2021 | 111,000.00 |
| Mar 31, 2021 | 62,000.00 |
API Access
Foghorn Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=FHTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "FHTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=FHTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();